Overview: In May 2021 Japan's Vaccines, human use exports accounted up to ¥513M and imports accounted up to ¥126B, resulting in a negative trade balance of ¥126B. Between May 2020 and May 2021 the exports of Japan's Vaccines, human use have increased by ¥90.3M (21.3%) from ¥423M to ¥513M, while imports increased by ¥124B (5.7k%) from ¥2.18B to ¥126B.
Destinations: In May 2021, Vaccines, human use were exported mostly to Taiwan (¥445M), Bangladesh (¥28.6M), Iraq (¥20.2M), Burundi (¥14.4M), and Lesotho (¥3.29M), and were imported mostly from Belgium (¥85.8B), United States (¥23.6B), Spain (¥14.1B), Ireland (¥2B), and France (¥731M).
Growth: In May 2021, the increase in Vaccines, human use's year-by-year exports was explained primarily by an increase in exports to . In May 2021, the increase in Vaccines, human use's year-by-year imports was explained primarily by an increase in imports from Belgium (¥85.8B or 397k%), United States (¥22.6B or 2.26k%), and Ireland (¥1.99B or 36.9k%).